{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:48:36Z","timestamp":1791348516562,"version":"4.3.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.08.008","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T04:15:01Z","timestamp":1313381701000},"page":"9159-9170","source":"Crossref","is-referenced-by-count":125,"title":["A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups"],"prefix":"10.1016","volume":"29","author":[{"given":"Barbara","family":"Michiels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Govaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Remmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.008_bib0005","unstructured":"World Health Organization. Recommended viruses for influenza vaccines for use in the 2010\u20132011 northern hemisphere influenza season: frequently asked questions. Geneva; 2010. p. 1\u20134. http:\/\/www.who.int\/csr\/disease\/influenza\/201002_RecommendationFAQ.pdf."},{"issue":"7","key":"10.1016\/j.vaccine.2011.08.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub4","article-title":"Vaccines for preventing influenza in healthy adults","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0015","doi-asserted-by":"crossref","first-page":"D17","DOI":"10.1016\/j.vaccine.2008.07.048","article-title":"Efficacy and effectiveness of influenza vaccination","volume":"26S","author":"Nichol","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0020","doi-asserted-by":"crossref","first-page":"D5","DOI":"10.1016\/j.vaccine.2008.05.076","article-title":"Seasonal inactivated influenza virus vaccines","volume":"26S","author":"Couch","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.08.008_bib0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00044011-200222110-00004","article-title":"Ten years of experience with the trivalent split-influenza vaccine, Fluarix","volume":"22","author":"Hehme","year":"2002","journal-title":"Clin Drug Invest"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2011.08.008_bib0030","doi-asserted-by":"crossref","first-page":"D14","DOI":"10.1016\/j.vaccine.2010.08.025","article-title":"Seasonal influenza vaccinations: specialized products for different target groups","volume":"28","author":"Monto","year":"2010","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2011.08.008_bib0035","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1016\/j.vaccine.2009.07.008","article-title":"Influenza vaccination and mortality benefits: new insights, new opportunities","volume":"27","author":"Simonsen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0040","series-title":"Guidance priority risk groups for influenza vaccination","author":"Nicoll","year":"2008"},{"issue":"RR-8","key":"10.1016\/j.vaccine.2011.08.008_bib0045","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0050","series-title":"Doelmatig gebruik van medische interventies bij de aanpak van influenza in de ambulante sector","author":"Comit\u00e9 voor de Evaluatie van de Medische Praktijk inzake Geneesmiddelen (CEG)[[nl]]Committee for the evaluation of medical practice","year":"2010"},{"issue":"10","key":"10.1016\/j.vaccine.2011.08.008_bib0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","article-title":"AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews","volume":"62","author":"Shea","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0060","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009]. The Cochrane Collaboration: www.cochrane-handbook.org; 2009.","DOI":"10.1002\/9780470712184"},{"issue":"7454","key":"10.1016\/j.vaccine.2011.08.008_bib0065","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0075","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"1\u201312","key":"10.1016\/j.vaccine.2011.08.008_bib0080","article-title":"Assessing the quality of reports of randomised controlled trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clin Trials"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005187.pub3","article-title":"Influenza vaccination for healthcare workers who work with the elderly","author":"Thomas","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006505.pub2","article-title":"Vaccines for prophylaxis of viral infections in patients with hematological malignancies","author":"Cheuk","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.008_bib0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1468-1293.2008.00515.x","article-title":"Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis","volume":"9","author":"Anema","year":"2008","journal-title":"HIV Med"},{"issue":"13","key":"10.1016\/j.vaccine.2011.08.008_bib0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.vaccine.2011.08.008_bib0105","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","article-title":"Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines","volume":"355","author":"Ohmit","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/589885","article-title":"Prevention of symptomatic seasonal influenza in 2005\u20132006 by inactivated and live attenuated vaccines","volume":"198","author":"Ohmit","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.008_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciq004","article-title":"Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety","volume":"52","author":"Madhi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.08.008_bib0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jpeds.2008.05.060","article-title":"Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial","volume":"153","author":"Jansen","year":"2008","journal-title":"J Pediatr"},{"issue":"15","key":"10.1016\/j.vaccine.2011.08.008_bib0125","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"issue":"9767","key":"10.1016\/j.vaccine.2011.08.008_bib0130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(10)62228-3","article-title":"Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"377","author":"Barrett","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2011.08.008_bib0135","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/656578","article-title":"Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults","volume":"51","author":"Frey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-10-71","article-title":"Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons","volume":"10","author":"Jackson","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2011.08.008_bib0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2010.250","article-title":"Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial","volume":"303","author":"Loeb","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.008_bib0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1071\/HI08003","article-title":"Effectiveness of influenza vaccine in preventing influenza-like illness among Faculty of Dentistry staff and students in University Kebangsaan Malaysia","volume":"13","author":"Hui","year":"2008","journal-title":"Healthc Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2011.08.008_bib0155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/INF.0b013e3181a487b4","article-title":"Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or noncomplicated acute otitis media","volume":"28","author":"Marchisio","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0160","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcv.2007.04.018","article-title":"Clinical impact of influenza immunization in patients with liver cirrhosis","volume":"39","author":"Song","year":"2007","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0170","first-page":"117","article-title":"Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease","volume":"33","author":"Anar","year":"2010","journal-title":"New Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1741-7015-4-17","article-title":"The effect of giving influenza vaccination to general practitioners: a controlled trial [NCT00221676]","volume":"4","author":"Michiels","year":"2006","journal-title":"BMC Med"},{"issue":"50","key":"10.1016\/j.vaccine.2011.08.008_bib0180","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1016\/j.vaccine.2009.09.067","article-title":"Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification","volume":"27","author":"Ochiai","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0185","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004879.pub3","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0190","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.008_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002733.pub2","article-title":"Influenza vaccine for patients with chronic obstructive pulmonary disease","author":"Poole","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0200","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000364.pub3","article-title":"Vaccines for preventing influenza in people with asthma","author":"Cates","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0205","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006316.pub2","article-title":"Influenza vaccine for children and adults with bronchiectasis","author":"Chang","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.008_bib0210","first-page":"CD001753","article-title":"Vaccines for preventing influenza in people with cystic fibrosis","author":"Dharmaraj","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005050.pub2","article-title":"Influenza vaccines for preventing coronary heart disease","author":"Keller","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0220","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006484.pub2","article-title":"Influenza vaccination in children being treated with chemotherapy for cancer","author":"Goossen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2011.08.008_bib0225","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.rmed.2005.07.001","article-title":"Preventing influenza: an overview of systematic reviews","volume":"99","author":"van der Wouden","year":"2005","journal-title":"Respir Med"},{"issue":"9","key":"10.1016\/j.vaccine.2011.08.008_bib0230","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/INF.0b013e3181e2872f","article-title":"The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination","volume":"29","author":"Ambrose","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0235","article-title":"Quantitative review of antibody response to inactivated seasonal influenza vaccines","author":"Seidman","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2011.08.008_bib0240","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2011.08.008_bib0245","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0250","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ije\/dyi293","article-title":"Commentary: benefits of influenza vaccine in US elderly-new studies raise questions","volume":"35","author":"Glezen","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0255","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.165.3.265","article-title":"Impact of influenza vaccination on seasonal mortality in the US elderly population","volume":"165","author":"Simonsen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.008_bib0260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.200802-282OC","article-title":"Mortality reduction with influenza vaccine in patients with pneumonia outside flu season: pleiotropic benefits or residual confounding?","volume":"178","author":"Eurich","year":"2008","journal-title":"Am J Respir Crit Care Med (United States)"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0265","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"14","key":"10.1016\/j.vaccine.2011.08.008_bib0270","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.008_bib0275","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ije\/dyl068","article-title":"Benefits of influenza vaccine in US elderly \u2013 appreciating issues of confounding bias and precision","volume":"35","author":"Hak","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.08.008_bib0280","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","article-title":"Mortality benefits of influenza vaccination in elderly people: an ongoing controversy","volume":"7","author":"Simonsen","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0285","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/649568","article-title":"Evidence of bias in studies of influenza vaccine effectiveness in elderly patients","volume":"201","author":"Baxter","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.008_bib0290","first-page":"368","article-title":"Meta analysis on the effectiveness of inactivated influenza vaccine","volume":"30","author":"Xing","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"9","key":"10.1016\/j.vaccine.2011.08.008_bib0295","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/jir015","article-title":"Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures","volume":"203","author":"Petrie","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0300","unstructured":"Hoge gezondheidsraad [High Council of Health]. Vaccinatie tegen seizoensgebonden griep Winterseizoen 2010\u20132011 [Vaccination against seasonal influenza \u2013 season 2010\u20132011], vol. 8682. Brussel; 2010. http:\/\/www.zorg-en-gezondheid.be\/griep.aspx#TOP."},{"issue":"35","key":"10.1016\/j.vaccine.2011.08.008_bib0305","first-page":"281","article-title":"Influenza vaccines: recommendations for the use of inactivated influenza vaccines and other preventive measures","volume":"75","author":"World Health Organization","year":"2000","journal-title":"Weekly Epidemiol Rec"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.008_bib0310","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"45","key":"10.1016\/j.vaccine.2011.08.008_bib0315","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1016\/j.vaccine.2010.08.088","article-title":"Effect of influenza vaccination on hospitalizations in persons aged 50 years and older","volume":"28","author":"Baxter","year":"2010","journal-title":"Vaccine"},{"issue":"9636","key":"10.1016\/j.vaccine.2011.08.008_bib0320","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(08)61160-5","article-title":"Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case\u2013control study","volume":"372","author":"Jackson","year":"2008","journal-title":"Lancet"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2011.08.008_bib0325","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/S0264-410X(02)00154-8","article-title":"Economic evaluation of strategies for the control and management of influenza in Europe","volume":"20","author":"Scuffham","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.008_bib0330","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7652","key":"10.1016\/j.vaccine.2011.08.008_bib0335","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2011.08.008_bib0340","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00019053-200927060-00001","article-title":"Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group","volume":"27","author":"Newall","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.008_bib0345","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations","volume":"66","author":"Bro\u017cek","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2011.08.008_bib0350","doi-asserted-by":"crossref","first-page":"D41","DOI":"10.1016\/j.vaccine.2008.07.043","article-title":"Correlates of protection: novel generations of influenza vaccines","volume":"26S","author":"Rimmelzwaam","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.008_bib0355","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.vaccine.2010.09.085","article-title":"Influenza vaccination for healthcare workers who work with the elderly: systematic review","volume":"29","author":"Thomas","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T02:07:02Z","timestamp":1560478022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":71,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11012175"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}